To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

IV tranexamic acid reduces blood loss and transfusion rate in primary THA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
February 2017

IV tranexamic acid reduces blood loss and transfusion rate in primary THA

Vol: 6| Issue: 2| Number:5| ISSN#: 2564-2537
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Meta-analysis of Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty

Orthopedics. 2016 Sep 1;39(5):e883-92

Contributing Authors:
JT Moskal SG Capps

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixteen randomized controlled trials (RCTs) were included in this meta-analysis evaluating the efficacy and safety of intravenous tranexamic acid in total hip arthroplasty. All included trials were placebo controlled. Results demonstrated significantly lower blood loss - including intraoperative blood loss, postoperative blood loss, and total blood loss - and transfusion rate with IV TXA versus pl...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue